IRIS
DEFERRARI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 22.959
AS - Asia 2.344
NA - Nord America 1.591
SA - Sud America 175
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 40
OC - Oceania 2
Totale 27.247
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 22.574
US - Stati Uniti d'America 1.480
SG - Singapore 1.013
CN - Cina 610
VN - Vietnam 299
BD - Bangladesh 215
FR - Francia 192
BR - Brasile 117
HK - Hong Kong 90
CH - Svizzera 43
DE - Germania 42
CA - Canada 34
MX - Messico 28
AR - Argentina 27
FI - Finlandia 21
GB - Regno Unito 21
JP - Giappone 21
IN - India 15
IQ - Iraq 14
ID - Indonesia 12
NL - Olanda 11
ZA - Sudafrica 11
PL - Polonia 9
EC - Ecuador 8
CO - Colombia 7
DZ - Algeria 7
GT - Guatemala 7
IE - Irlanda 7
MA - Marocco 7
PH - Filippine 7
SC - Seychelles 7
JM - Giamaica 6
RU - Federazione Russa 6
UA - Ucraina 6
VE - Venezuela 6
AZ - Azerbaigian 5
ES - Italia 5
HN - Honduras 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KR - Corea 4
PK - Pakistan 4
PR - Porto Rico 4
PY - Paraguay 4
SA - Arabia Saudita 4
TR - Turchia 4
DK - Danimarca 3
JO - Giordania 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
EG - Egitto 2
GP - Guadalupe 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
PE - Perù 2
RS - Serbia 2
SV - El Salvador 2
TH - Thailandia 2
UZ - Uzbekistan 2
AD - Andorra 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LV - Lettonia 1
MF - Saint Martin 1
ML - Mali 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MY - Malesia 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 27.112
Salva come PNG Salva come JPEG
Città #
Genova 14.508
Genoa 4.451
Rapallo 2.153
Vado Ligure 1.298
Singapore 512
San Jose 435
Lauterbourg 182
Ashburn 138
New York 97
Beijing 95
Hanoi 84
Hong Kong 84
Ho Chi Minh City 78
Bordighera 51
Santa Clara 49
Zurich 43
Frankfurt am Main 35
Los Angeles 33
Helsinki 21
Mexico City 19
Tokyo 18
Dallas 16
Rome 16
Tianjin 16
Chicago 14
Buffalo 13
Orem 13
São Paulo 13
Da Nang 12
Haiphong 11
Phoenix 11
Houston 10
Atlanta 9
Baghdad 9
Philadelphia 9
Brooklyn 8
San Francisco 8
Amsterdam 7
Biên Hòa 7
City of London 7
Council Bluffs 7
Dublin 7
Milan 7
Toronto 7
Washington 7
Fort Worth 6
Las Vegas 6
Naples 6
San Antonio 6
The Bronx 6
Denver 5
Jacksonville 5
Johannesburg 5
London 5
Montreal 5
Orangeburg 5
St Louis 5
Bologna 4
Charlotte 4
Guangzhou 4
Iowa City 4
Kansas City 4
Lexington 4
Louisville 4
Madrid 4
Orland Park 4
Pasadena 4
Plainfield 4
Richmond 4
Tampa 4
Topeka 4
Turin 4
Baku 3
Bogotá 3
Brasília 3
Bắc Ninh 3
Cao Lanh 3
Cardiff 3
Chaguanas 3
Charleston 3
Cincinnati 3
Concord 3
Des Moines 3
Guayaquil 3
Harrisburg 3
Kingston 3
Minneapolis 3
Mumbai 3
Pittsburgh 3
Quảng Ngãi 3
San Juan 3
Seattle 3
Shanghai 3
Tegucigalpa 3
Thái Bình 3
Tây Ninh 3
Verona 3
Warsaw 3
Akron 2
Alameda 2
Totale 24.835
Salva come PNG Salva come JPEG
Nome #
L'AMMONIOGENESI RENALE NELL'UOMO 337
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy 219
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 212
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 205
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 203
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 202
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 192
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 191
C-reactive protein and target organ damage in untreated patients with primary hypertension. 186
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 184
Interorgan exchange of aminothiols in humans 180
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 180
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 179
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 177
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 176
Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. 175
Inter-organ leptin exchange in humans 175
Renal and cardiac abnormalities in primary hypertension 174
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 172
Blood pressure variability and multiple organ damage in primary hypertension 172
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 170
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. 168
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 167
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 165
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 165
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 163
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 162
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 162
Amino acid imbalance in patients with chronic renal failure. 159
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 159
PROTEIN TURNOVER IN THE HUMAN KIDNEY 158
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 158
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 158
Creatinine clearance and early signs of target organ damage in primary hypertension 157
Sub-clinical organ damage in hypertension and obesity 157
136) CKD awareness and blood pressare control in the primari care hypertensive population 156
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II 156
Mechanisms of renal ammonia production and protein turnover 156
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 155
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 154
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 153
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 152
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 152
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study 152
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 152
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 151
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 151
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 151
Mild renal dysfunction and renal vascular resistance in primary hypertension 150
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 149
Phenylalanine hydroxylation across the kidney in humans 148
Renal ammoniagenesis in an early stage of metabolic acidosis in man 148
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 148
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 146
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 145
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 144
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 143
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 143
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 143
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestion 143
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 143
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 142
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 142
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 142
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 141
BRAIN METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY 141
Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients 141
AMINO ACID BIOSYNTHESIS 140
RENAL METABOLISM OF C-PEPTIDE IN MAN 140
Renal ammoniagenesis during the adaptation to metabolic acidosis in man. 140
[Acute effects of peritoneal dialysis on muscle protein turnover]. 140
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 139
Emerging therapeutic strategies in diabetic nephropathy 139
Disposal of exogenous amino acids by muscle in patients with chronic renal failure 139
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 139
Serum uric acid as a marker of target organ damage in primary hypertension 138
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 138
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 137
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 137
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 136
Renal ammoniagenesis in humans with chronic potassium depletion 136
LEG METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL FAILURE 136
Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency 135
AMINO ACID METABOLISM IN RENAL FAILURE 135
EFFETTI DELLE VARIAZIONI DEL pH DEL BAGNO DI DIALISI SULL'EQUILIBRIO ACIDO-BASE (EAB) DEI PAZIENTI IN CORSO DI EMODIALISI 134
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure 134
EFFECT OF AMINO ACID INGESTION ON BLOOD AMINO ACID PROFILE IN PATIENTS WITH CHRONIC RENAL FAILURE 134
WHOLE BODY AND ORGAN PROTEIN TURNOVER IN CHRONIC RENAL FAILURE 133
EFFETTI DELL'INSUFFICIENZA RENALE CRONICA SUL METABOLISMO DELLA TIROSINA E DELLA FENILALANINA. 133
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. 133
Abnormalities in blood amino acid profile after a protein meal in patients with chronic renal failure. Kidney Int Suppl. 1989 Nov;27:S212-5. 132
Blood pressure load, vascular permeability and target organ damage in primary hypertension 131
Ammonia and amino acid metabolism y the portal-vein-drained viscera in chronic renal insufficiency. 131
Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney 131
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein synthesis and degradation 131
Testosterone promotes apoptotic damage in human renal tubular cells 131
Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells 130
Global risk stratification in primary hypertension: the role of the kidney 130
LEUCINE METABOLISM AND PROTEIN DYNAMICS IN THE HUMAN KIDNEY 130
TT virus infection in haemodialysis patients 130
Totale 15.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.029
article - articoli 72.963
book - libri 0
conference - conferenze 4.710
curatela - curatele 0
other - altro 741
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.615
Totale 166.058
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.592 56 213 142 322 126 187 192 589 69 215 152 329
2022/20232.571 240 115 30 265 421 489 3 238 462 14 248 46
2023/20241.058 66 165 19 108 80 151 43 88 75 9 100 154
2024/20253.055 45 254 86 185 501 322 245 402 142 159 348 366
2025/20265.368 609 109 242 438 688 613 962 253 313 483 271 387
2026/2027554 554 0 0 0 0 0 0 0 0 0 0 0
Totale 27.247